PUBLISHER: 360iResearch | PRODUCT CODE: 1608043
PUBLISHER: 360iResearch | PRODUCT CODE: 1608043
Hyoscine Market by Type (Hyoscine Butylbromide, Hyoscine Hydrobromide), Mode of Administration (Injections, Oral, Patches) - Global Forecast 2025-2030
The Hyoscine Market was valued at USD 439.16 million in 2023, expected to reach USD 460.41 million in 2024, and is projected to grow at a CAGR of 4.66%, to USD 604.28 million by 2030.
Hyoscine, also known as scopolamine, is an alkaloid medication primarily used to treat motion sickness and postoperative nausea and vomiting. It is found in certain plants of the nightshade family and operates as an anticholinergic agent, blocking the neurotransmitter acetylcholine in the central and the peripheral nervous system. The necessity of hyoscine arises from its effectiveness in preventing nausea and its application extends to treatment of other conditions such as irritable bowel syndrome and muscle spasms, providing a multifaceted scope for the pharmaceutical industry. It is most commonly utilized in transdermal patch form, oral tablets, and intravenous injections, allowing widespread end-use in clinical settings, over-the-counter products, and emergency care. The market for hyoscine is significantly influenced by factors such as an increasing prevalence of motion sickness due to rising travel activities, expanding applications in gastrointestinal treatments, and ongoing research into neurodegenerative disease therapies. Opportunities lie in expanding the use in veterinary medicine, and formulating new delivery methods that enhance efficacy or reduce side effects. To capture these opportunities, investing in advanced R&D and collaboration with travel industry stakeholders is recommended, thereby enhancing product visibility and acceptance. However, growth is hindered by factors like stringent regulatory frameworks, potential side effects common to anticholinergics, including dry mouth, drowsiness, and blurred vision, and the competition from alternative therapies. Innovations may focus on developing hyoscine derivatives with higher selectivity, reducing adverse effects, and exploring potential use in cognitive disorders, such as Alzheimer's disease. The market is competitive yet promising, driven by expanding therapeutic applications and growing demand in emerging economies. Businesses must align their strategies to emerging consumer needs and regulatory landscapes to harness the full market potential of hyoscine.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 439.16 million |
| Estimated Year [2024] | USD 460.41 million |
| Forecast Year [2030] | USD 604.28 million |
| CAGR (%) | 4.66% |
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Hyoscine Market
The Hyoscine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
- Growing number of travelers and international tourism
- Availability of hyoscine as over-the-counter medicine
- Market Restraints
- High cost and stringent regulatory protocols
- Market Opportunities
- Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
- Improvements in production process of hyoscine
- Market Challenges
- Side effects associated with hyoscine
Porter's Five Forces: A Strategic Tool for Navigating the Hyoscine Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Hyoscine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Hyoscine Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Hyoscine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Hyoscine Market
A detailed market share analysis in the Hyoscine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Hyoscine Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Hyoscine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Hyoscine Market
A strategic analysis of the Hyoscine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Hyoscine Market, highlighting leading vendors and their innovative profiles. These include Alchem International Pvt. Ltd., Alkaloids Corporation, Baxter International, Inc., C-Squared Pharma S.a R.L., Caleb Pharmaceuticals, Inc, GlaxoSmithKline PLC, Linnea SA, Merck KGaA, Morningside Healthcare Limited by Aspire Pharma Limited, Myungmoon Pharm Co., Ltd., Perrigo Company PLC, Pfizer Inc., Sanofi S.A., Teva Pharmaceuticals Industries Ltd., and Wockhardt UK Limited.
Market Segmentation & Coverage
This research report categorizes the Hyoscine Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Type, market is studied across Hyoscine Butylbromide and Hyoscine Hydrobromide.
- Based on Mode of Administration, market is studied across Injections, Oral, and Patches.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Increasing awareness about the use of hyoscine as an apt medicine against motion sickness
- 5.1.1.2. Growing number of travelers and international tourism
- 5.1.1.3. Availability of hyoscine as over-the-counter medicine
- 5.1.2. Restraints
- 5.1.2.1. High cost and stringent regulatory protocols
- 5.1.3. Opportunities
- 5.1.3.1. Increase in usage of transdermal hyoscine patches in surgeries & post-operative recovery
- 5.1.3.2. Improvements in production process of hyoscine
- 5.1.4. Challenges
- 5.1.4.1. Side effects associated with hyoscine
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Hyoscine Market, by Type
- 6.1. Introduction
- 6.2. Hyoscine Butylbromide
- 6.3. Hyoscine Hydrobromide
7. Hyoscine Market, by Mode of Administration
- 7.1. Introduction
- 7.2. Injections
- 7.3. Oral
- 7.4. Patches
8. Americas Hyoscine Market
- 8.1. Introduction
- 8.2. Argentina
- 8.3. Brazil
- 8.4. Canada
- 8.5. Mexico
- 8.6. United States
9. Asia-Pacific Hyoscine Market
- 9.1. Introduction
- 9.2. Australia
- 9.3. China
- 9.4. India
- 9.5. Indonesia
- 9.6. Japan
- 9.7. Malaysia
- 9.8. Philippines
- 9.9. Singapore
- 9.10. South Korea
- 9.11. Taiwan
- 9.12. Thailand
- 9.13. Vietnam
10. Europe, Middle East & Africa Hyoscine Market
- 10.1. Introduction
- 10.2. Denmark
- 10.3. Egypt
- 10.4. Finland
- 10.5. France
- 10.6. Germany
- 10.7. Israel
- 10.8. Italy
- 10.9. Netherlands
- 10.10. Nigeria
- 10.11. Norway
- 10.12. Poland
- 10.13. Qatar
- 10.14. Russia
- 10.15. Saudi Arabia
- 10.16. South Africa
- 10.17. Spain
- 10.18. Sweden
- 10.19. Switzerland
- 10.20. Turkey
- 10.21. United Arab Emirates
- 10.22. United Kingdom
11. Competitive Landscape
- 11.1. Market Share Analysis, 2023
- 11.2. FPNV Positioning Matrix, 2023
- 11.3. Competitive Scenario Analysis
- 11.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Alchem International Pvt. Ltd.
- 2. Alkaloids Corporation
- 3. Baxter International, Inc.
- 4. C-Squared Pharma S.a R.L.
- 5. Caleb Pharmaceuticals, Inc
- 6. GlaxoSmithKline PLC
- 7. Linnea SA
- 8. Merck KGaA
- 9. Morningside Healthcare Limited by Aspire Pharma Limited
- 10. Myungmoon Pharm Co., Ltd.
- 11. Perrigo Company PLC
- 12. Pfizer Inc.
- 13. Sanofi S.A.
- 14. Teva Pharmaceuticals Industries Ltd.
- 15. Wockhardt UK Limited
LIST OF FIGURES
- FIGURE 1. HYOSCINE MARKET RESEARCH PROCESS
- FIGURE 2. HYOSCINE MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 11. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 13. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 15. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 19. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. HYOSCINE MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL HYOSCINE MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL HYOSCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. HYOSCINE MARKET DYNAMICS
- TABLE 7. GLOBAL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE BUTYLBROMIDE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL HYOSCINE MARKET SIZE, BY HYOSCINE HYDROBROMIDE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL HYOSCINE MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL HYOSCINE MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL HYOSCINE MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. AMERICAS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 15. AMERICAS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 16. AMERICAS HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 17. ARGENTINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 18. ARGENTINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 19. BRAZIL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 20. BRAZIL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 21. CANADA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 22. CANADA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 23. MEXICO HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 24. MEXICO HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 25. UNITED STATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 26. UNITED STATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 27. UNITED STATES HYOSCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 28. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 29. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 30. ASIA-PACIFIC HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 31. AUSTRALIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 32. AUSTRALIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 33. CHINA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 34. CHINA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 35. INDIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 36. INDIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 37. INDONESIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 38. INDONESIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 39. JAPAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 40. JAPAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 41. MALAYSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 42. MALAYSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 43. PHILIPPINES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 44. PHILIPPINES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 45. SINGAPORE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 46. SINGAPORE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 47. SOUTH KOREA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 48. SOUTH KOREA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 49. TAIWAN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 50. TAIWAN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 51. THAILAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 52. THAILAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 53. VIETNAM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 54. VIETNAM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 55. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 56. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 57. EUROPE, MIDDLE EAST & AFRICA HYOSCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 58. DENMARK HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 59. DENMARK HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 60. EGYPT HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 61. EGYPT HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 62. FINLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 63. FINLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 64. FRANCE HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 65. FRANCE HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 66. GERMANY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 67. GERMANY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 68. ISRAEL HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 69. ISRAEL HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 70. ITALY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 71. ITALY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 72. NETHERLANDS HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 73. NETHERLANDS HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 74. NIGERIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 75. NIGERIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 76. NORWAY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 77. NORWAY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 78. POLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 79. POLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 80. QATAR HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 81. QATAR HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 82. RUSSIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 83. RUSSIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 84. SAUDI ARABIA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 85. SAUDI ARABIA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 86. SOUTH AFRICA HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 87. SOUTH AFRICA HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 88. SPAIN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 89. SPAIN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 90. SWEDEN HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 91. SWEDEN HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 92. SWITZERLAND HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 93. SWITZERLAND HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 94. TURKEY HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 95. TURKEY HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 96. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 97. UNITED ARAB EMIRATES HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 98. UNITED KINGDOM HYOSCINE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
- TABLE 99. UNITED KINGDOM HYOSCINE MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
- TABLE 100. HYOSCINE MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 101. HYOSCINE MARKET, FPNV POSITIONING MATRIX, 2023
